Side-by-side comparison of AI visibility scores, market position, and capabilities
Sony (NYSE: SONY) gaming platform with 135M+ PSN users, 47M+ PlayStation Plus subscribers at $25B+ FY2024 segment revenue; PS5 exclusive franchises competing with Microsoft Xbox Game Pass for console gaming market leadership.
PlayStation is the gaming brand of Sony Group Corporation (TYO: 6758 / NYSE: SONY) — the global consumer electronics and entertainment conglomerate generating ¥13+ trillion ($88B+) in annual revenue — operating the PlayStation 5 console platform (110M+ PS5 units sold by 2025), PlayStation Network (135M+ monthly active users), PlayStation Plus subscription service (47M+ paid subscribers across Essential, Extra, and Premium tiers), and PlayStation Studios (19 first-party game studios producing exclusive franchises including God of War, Spider-Man/Marvel, Horizon, The Last of Us, Gran Turismo, and Ghost of Tsushima). Sony's game and network services segment generated approximately $25 billion+ in revenue in fiscal year 2024, making it the largest revenue segment within Sony Group and the second-largest gaming platform by revenue after Microsoft's Xbox/Activision combined entity.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.